These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38096689)

  • 21. Pandemic Uropathogenic Fluoroquinolone-resistant Escherichia coli Have Enhanced Ability to Persist in the Gut and Cause Bacteriuria in Healthy Women.
    Tchesnokova VL; Rechkina E; Chan D; Haile HG; Larson L; Ferrier K; Schroeder DW; Solyanik T; Shibuya S; Hansen K; Ralston JD; Riddell K; Scholes D; Sokurenko EV
    Clin Infect Dis; 2020 Feb; 70(5):937-939. PubMed ID: 31271206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis.
    Worby CJ; Sridhar S; Turbett SE; Becker MV; Kogut L; Sanchez V; Bronson RA; Rao SR; Oliver E; Walker AT; Walters MS; Kelly P; Leung DT; Knouse MC; Hagmann SHF; Harris JB; Ryan ET; Earl AM; LaRocque RC
    Lancet Microbe; 2023 Oct; 4(10):e790-e799. PubMed ID: 37716364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR; Johnston B; Clabots C; Kuskowski MA; Castanheira M
    Clin Infect Dis; 2010 Aug; 51(3):286-94. PubMed ID: 20572763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of O25b-ST131
    Hajihasani A; Ebrahimi-Rad M; Rasoulinasab M; Aslani MM; Shahcheraghi F
    Microb Drug Resist; 2022 Feb; 28(2):210-216. PubMed ID: 34698555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, Incidence, and Risk Factors for Intestinal Colonization Due to Fluoroquinolone-Resistant ST131 Escherichia coli: a Longitudinal Study in Highly Dependent, Long-Term Care Facility Residents.
    Salamanca-Rivera E; López-Cerero L; Rodríguez-Martínez JM; Pascual A; Rodríguez-Baño J
    Microbiol Spectr; 2022 Aug; 10(4):e0167322. PubMed ID: 35943257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
    Johnston BD; Thuras P; Porter SB; Anacker M; VonBank B; Vagnone PS; Witwer M; Castanheira M; Johnson JR
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global Escherichia coli Sequence Type 131 Clade with bla
    Matsumura Y; Pitout JD; Gomi R; Matsuda T; Noguchi T; Yamamoto M; Peirano G; DeVinney R; Bradford PA; Motyl MR; Tanaka M; Nagao M; Takakura S; Ichiyama S
    Emerg Infect Dis; 2016 Nov; 22(11):1900-1907. PubMed ID: 27767006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seven-year surveillance of the prevalence of antimicrobial-resistant Escherichia coli isolates, with a focus on ST131 clones, among healthy people in Osaka, Japan.
    Fukuda A; Nakamura H; Umeda K; Yamamoto K; Hirai Y; Usui M; Ogasawara J
    Int J Antimicrob Agents; 2021 Mar; 57(3):106298. PubMed ID: 33556490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonization with
    Johnston BD; Clabots C; Bender T; Porter SB; van den Dobbelsteen G; Poolman J; Thuras P; Johnson JR
    Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan.
    Huang IF; Lee WY; Wang JL; Hung CH; Hu HH; Hung WY; Hung YJ; Chen WC; Shen YT; Cheng MF
    BMC Gastroenterol; 2018 Jun; 18(1):86. PubMed ID: 29907090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of ESBL-Producing
    Zendri F; Maciuca IE; Moon S; Jones PH; Wattret A; Jenkins R; Baxter A; Timofte D
    Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
    Santona A; Sumbana JJ; Fiamma M; Deligios M; Taviani E; Simbine SE; Zimba T; Sacarlal J; Rubino S; Paglietti B
    Int J Antimicrob Agents; 2022 Oct; 60(4):106649. PubMed ID: 35934230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.
    Johnson JR; Clermont O; Johnston B; Clabots C; Tchesnokova V; Sokurenko E; Junka AF; Maczynska B; Denamur E
    J Clin Microbiol; 2014 May; 52(5):1358-65. PubMed ID: 24501035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131.
    Stoesser N; Sheppard AE; Pankhurst L; De Maio N; Moore CE; Sebra R; Turner P; Anson LW; Kasarskis A; Batty EM; Kos V; Wilson DJ; Phetsouvanh R; Wyllie D; Sokurenko E; Manges AR; Johnson TJ; Price LB; Peto TE; Johnson JR; Didelot X; Walker AS; Crook DW;
    mBio; 2016 Mar; 7(2):e02162. PubMed ID: 27006459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of diversity in carbapenemase-producing
    Ellaby N; Doumith M; Hopkins KL; Woodford N; Ellington MJ
    Euro Surveill; 2019 Sep; 24(37):. PubMed ID: 31530344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
    Johnston BD; Thuras P; Porter SB; Clabots C; Johnson JR
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2069-2075. PubMed ID: 33893571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.